Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
50,518,873
-
Total 13F shares
-
49,181,489
-
Share change
-
+1,344,595
-
Total reported value
-
$1,786,701,511
-
Put/Call ratio
-
540%
-
Price per share
-
$36.33
-
Number of holders
-
132
-
Value change
-
+$50,897,730
-
Number of buys
-
58
-
Number of sells
-
65
Institutional Holders of Immunocore Holdings plc - ADR (IMCR) as of Q3 2025
As of 30 Sep 2025,
Immunocore Holdings plc - ADR (IMCR) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,181,489 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, PRIMECAP MANAGEMENT CO/CA/, Bellevue Group AG, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, and BVF INC/IL.
This page lists
132
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.